Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report

Br J Haematol. 2024 Apr;204(4):1540-1544. doi: 10.1111/bjh.19289. Epub 2024 Jan 11.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anemia, Sickle Cell* / therapy
  • Antibodies, Monoclonal / therapeutic use
  • HLA Antigens
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Tissue Donors

Substances

  • daratumumab
  • Antibodies, Monoclonal
  • HLA Antigens